https://medicaex.com/prnewswire/menarini-group-announces-new-data-on-elzonris-tagraxofusp-erzs-to-be-presented-at-the-67th-american-society-of-hematology-annual-meeting-and-exposition/
Nov 29, 2025
menarinigroupannouncesnewdata
https://pubmed.ncbi.nlm.nih.gov/31018069/?dopt=Abstract
In adult patients with untreated or relapsed BPDCN, the use of tagraxofusp led to clinical responses. Serious adverse events included capillary leak syndrome;...
plasmacytoid dendritic celltagraxofuspblasticneoplasm